Date published: 2026-5-17

1-800-457-3801

SCBT Portrait Logo
Seach Input

OR7C2 Inhibitors

OR7C2 is a protein that could play a significant role in cellular processes. The expression of proteins like OR7C2 is tightly regulated within the cell, where various signaling pathways and transcriptional mechanisms maintain the delicate balance of protein synthesis. Disruptions in the expression of such proteins may have cascading effects on cellular function, and thus, understanding the molecules that can inhibit gene expression is a critical area of research. Chemical compounds have the potential to interact with biomolecules and cellular structures, leading to changes in the expression levels of specific proteins. The inhibition of protein expression can occur at various stages of gene expression, from the unwinding of DNA to the post-transcriptional modification of mRNA. Some compounds might bind directly to DNA, blocking transcription factors or interfering with RNA polymerase binding and function. Others may interact with epigenetic markers, altering the histone code and thus affecting the chromatin state and gene accessibility. Furthermore, inhibitors can also affect the stability and translation of mRNA, providing multiple checkpoints at which protein expression can be downregulated. Among the array of chemicals that could inhibit the expression of OR7C2, several have been identified based on their known biochemical interactions. For instance, Trichostatin A, a histone deacetylase inhibitor, can lead to a more open chromatin state, potentially reducing transcriptional activity at gene loci such as that of OR7C2. Mitomycin C, through its DNA crosslinking action, could prevent the transcriptional machinery from accessing the OR7C2 gene, thus leading to decreased expression. Chloroquine, by accumulating in lysosomes and affecting autophagic processes, might alter cellular stress responses and thereby reduce the levels of certain proteins. Additionally, compounds like 5-Azacytidine and SN-38 target DNA methylation and topoisomerase I, respectively, both of which are crucial for the transcription and subsequent expression of proteins. By understanding the action of these inhibitors at the molecular level, researchers can elucidate the pathways that control gene expression, shedding light on the intricate web of interactions that govern cellular function.

Items 11 to 12 of 12 total

Display:

Product NameCAS #Catalog #QUANTITYPriceCitationsRATING

PD 98059

167869-21-8sc-3532
sc-3532A
1 mg
5 mg
$40.00
$92.00
212
(2)

PD 98059 may inhibit the MEK1/2, which are upstream in the MAPK pathway, potentially leading to a decreased expression of OR7C2 by suppressing the pathway's transcriptional activity.

SN 38

86639-52-3sc-203697
sc-203697A
sc-203697B
10 mg
50 mg
500 mg
$119.00
$342.00
$883.00
19
(3)

The active metabolite of irinotecan, SN 38, can inhibit topoisomerase I, leading to a decrease in OR7C2 expression by causing DNA damage and cell cycle arrest, which limits the transcription process.